UGT1A1 and Hyperbilirubinemia: Overall analyses suggested an increased risk of hyperbilirubinemia in HIV-positive patients with a UGT1A1*28/*28 genotype as compared with those with a wild-type genotype (OR = 10.07, 95%CI = 4.39–23.10; P<0.00001).